Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results